Product Information
MEGESTROL 625 MG/5 ML SUSP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $1.4403 per ML under NDC 24979004113. Its NADAC has been published 568 times since Nov 18, 2015.
FDA first approved this application on Aug 27, 2014.
The High Outlier badge above means this manufacturer's average price in the Megestrol Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
125 mg/mL
Manufacturer
Upsher-Smith Laboratories LLCNDC
24979004113
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEGESTROL ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA203139FDA Approved
8/27/2014
On Market Since
3/1/2015
Pharmacological Classes
Price Statistics
The NADAC for MEGESTROL 625 MG/5 ML SUSP has been published 568 times since Nov 18, 2015, and over the history we have for it it has declined 62.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4403 per ML |
|---|---|
| All-time high | $4.0820 (Jan 13, 2016) |
| All-time low | $0.8523 (Jun 19, 2024) |
| 52-week high | $1.4403 |
| 52-week low | $1.1596 |
| Median price | $1.7943 |
| Average price | $1.9813 |
| Largest weekly change | +35.3% (Aug 18, 2021) |
| Weeks tracked | 568 |
| Tracking since | Nov 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Megestrol Acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Megestrol Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEGESTROL 625 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for MEGESTROL 625 MG/5 ML SUSP, manufactured by Upsher-Smith Laboratories LLC, is $1.4403 per ML (NDC 24979004113), effective Sep 30, 2026.
How has the price of MEGESTROL 625 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for MEGESTROL 625 MG/5 ML SUSP has declined 62.4%. It has been tracked across 568 weekly CMS publications since Nov 18, 2015.
What are the highest and lowest recorded NADAC prices for MEGESTROL 625 MG/5 ML SUSP?
Since Nov 18, 2015, the NADAC for MEGESTROL 625 MG/5 ML SUSP has ranged from a low of $0.8523 (Jun 19, 2024) to a high of $4.0820 (Jan 13, 2016), with a median of $1.7943 per ML.
Are there cheaper alternatives to MEGESTROL 625 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of MEGESTROL 625 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEGESTROL 625 MG/5 ML SUSP?
MEGESTROL 625 MG/5 ML SUSP (NDC 24979004113) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.